Homeopathic treatment of white patches on skin

Effectiveness of individualized homoeopathic medicines and Psoralea corylifolia mother tincture external application in vitiligo: an open randomized pragmatic trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013446

Enrollment

Registered

2018-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Indicated homeopathic medicines in centesimal or fifty millesimal potencies: Indicated homeopathic medicines in centesimal or fifty millesimal potencies, as decided appropriate to the c

dosage and repetition depending upon the individual requirement of the cases. In 50 millesimal scale, a single medicated cane sugar globules of poppy seed size (no. 10) shall be dissolved in 90 ml dis

16 doses to be marked on the vial

each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th

to apply locally by moistening cotton with the medicine, followed by exposure to sunlight for minimum 15 minutes. If local irritation becomes troublesome, the medicine will be diluted in 1:10 ratio in

otherwise the patient will be discontinued from the study. Duration of therapy: 6 months Control Intervention2: Indicated homeopathic medicines in centesimal or fifty millesimal potencies plus Psorale

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years 2. Both sexes 3. Literate; able to read English or Bengali 4. Suffering from vitiligo for at least last 3 months

Exclusion criteria

Exclusion criteria: 1. Patients who are too sick for consultation 2. Patients not giving consent to take part 3. Diagnosed cases of unstable psychiatric illness or other systemic disease or infection affecting quality of life or any vital organ failure 4. Pregnancy and lactation 5. Self-reported immune-compromised state 6. Substance abuse and/or dependence 7. Undergoing homeopathic treatment for any chronic disease within last 6 months

Design outcomes

Primary

Measure	Time frame
Vitiligo Area Scoring Index (VASI)Timepoint: Baseline, after 3 months and after 6 months	—

Secondary

Measure	Time frame
Dermatological Life Quality Index (DLQI) questionnaireTimepoint: Baseline, after 3 months and after 6 months;Vitiligo Quality of Life Questionnaire (VitiQoL)Timepoint: Baseline, after 3 months and after 6 months	—

Countries

India

Contacts

Public ContactAnaitullah Ahmad Mir

National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India

civildefence12@gmail.com7006951253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026